Petros Pharmaceuticals Inc (PTPI) Up 1.27% in Premarket Trading

Tuesday, March 26, 2024 08:34 AM | InvestorsObserver Analysts

Mentioned in this article

Petros Pharmaceuticals Inc (PTPI) has gained Tuesday morning, with the stock rising 1.27% in pre-market trading to 1.59. PTPI's short-term technical score of 47 indicates that the stock has traded less bullishly over the last month than 53% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 96 out of 146 industries, PTPI ranks higher than 59% of stocks. Petros Pharmaceuticals Inc has fallen 4.85% over the past month, closing at $1.66 on February 27. During this period of time, the stock fell as low as $1.38 and as high as $1.76. PTPI has an average analyst recommendation of Strong Buy. The company has an average price target of $4.00.

PTPI has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on PTPI!
Petros Pharmaceuticals Inc has a Long-Term Technical rank of 59. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 41% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 87 by this metric, PTPI ranks better than 87% of stocks.

Important Dates for Investors in PTPI:

-Petros Pharmaceuticals Inc is set to release earnings on 2024-03-27. Over the last 12 months, the company has reported EPS of $-6.21. -We do not have a set dividend date for Petros Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Petros Pharmaceuticals Inc (PTPI)

Share this article: